On November 10th, PANTHERx Chairman and CEO Dr. Gordon J. Vanscoy was named to the “2016 Pittsburgh Smart 50,” which honors the top executives at the “50 smartest companies in Pittsburgh” for their leadership and contributions to the companies they have built.
From the website of Smart Business:
“Chairman and CEO Gordon J. Vanscoy, PharmD, possess three decades of executive experience, creating and leading successful medical/pharmaceutical service businesses. Vanscoy is also the associate dean for business innovation and associate professor at the University of Pittsburgh School of Pharmacy.
From its start in 2011, PANTHERx Specialty Pharmacy sought to reinvent specialty pharmacy, revolutionize pharmacy and redefine care. With three former students, Vanscoy positioned PANTHERx in the niche of managing rare and devastating diseases, including those requiring personalized or orphan drugs. The big specialty pharmacies weren’t geared for the unique needs of these complex disorders; PANTHERx was.
PANTHERx landed an exclusive biotech partnership in 2015, managing a new life-saving orphan drug for the entire country. Since, the company expanded to a state-of-the-art facility to keep up with the growth.
In addition to new agreements with states, health plans and prescriber offices, the biotechnology industry now routinely seeks out PANTHERx as the rare disease partner to help launch new medicines.”
You can find out more about the Smart 50 at this link.